POST 7th_NIF
> ATTENDEES
​> INVESTORS
> PRESENTERS
> SPONSORS
​> SUPPORTERS

3B Future Health Ventures
AAA Family Office
AbbVie, Inc.
Acasti Pharma Inc.
Accequa AB
Acelot, Inc.
Aclipse Therapeutics
Actinogen Medical Ltd.
Acurex Biosciences
Aescuvest International GmbH
age1
AgenT S.A.S.
Albion Ventures LLP
ALCEDIAG
Alexander Shulgin Research Institute
Alfidi Capital
AlgoTx
Allele Capital Partners, LLC
Alpha Bronze
ALSA Ventures
Alta Holdings
Amyl Therapeutics
Andera Partners
Angelini Pharma S.p.a.
Angelini Ventures S.p.A.
Aprecia Pharmaceuticals
Aptar Digital Health
Aqua Partners LLC
ARCH Venture Partners
ASDERA LLC
Astellas Venture Management LLC
Astrocyte Pharmaceuticals
atai Life Sciences N.V.
ATEM Capital
Avadel Pharmaceuticals plc
Axoltis Pharma
Beckley Psytech
BioCentury, Inc.
Biogen
BioHealth Innovation, Inc.
BioSymetrics, Inc.
BiotechGate
Biovision Ventures
Bison Ventures
Bloom Science
Boehringer Ingelheim International GmbH
BOHE Angel Fund
BrainTale
Brandon Capital
Breslin AG
Broad Institute of MIT and Harvard
BROTHERS & PARTNERS (MFO)
BTIG, LLC
Canaccord Genuity LLC
Cassel Salpeter LLC
CBT Advisors
Centre for Aging + Brain Health Innovation (CABHI)
CereCura Nanotherapeutics
CervoMed Inc.
CIlcare
Clexio Biosciences Ltd.
Cognition Therapeutics, Inc.
Cohesion Bureau
Coho VC
Compass Pathways
Corundum Neuroscience
CTI Life Sciences Fund
CuraSen Therapeutics, Inc.
Cybin Inc.
Daewoong Pharmaceutical Co., Ltd.
David Fox Syndicate
DCVC Bio
Decheng Capital LLC
Delix Therapeutics
Dementia Discovery Fund - SV Health Investors LLP
Dolby Family Ventures, L.P.
Dorset Capital LLC
Earlybird Venture Capital
Edison Group
Eight Roads
Eight Roads Ventures
Eikonizo Therapeutics, Inc
Eisai Innovation Inc.
Eli Lilly and Company
Excellent Capital LLC
Feel Therapeutics
Ferghana Partners, Inc.
Find Therapeutics Inc.
Foothill Ventures
Fortunatus Capital
Frazier Life Sciences
FreeMind Group
GAIA AG
Gain Therapeutics, Inc.
Galimedix Therapeutics, Inc.
Gate Neurosciences, Inc.
GenEp, Inc.
Generation Capital, LLC
Generation Fund Life Sciences Fund I
GeNeuro SA
GliaPharm SA
Global Alpha Ventures
GLSV GmbH iL, MicroCures Inc, Neurevo GmbH, 3Brain AG
GreenSky Capital Inc.
H. Lundbeck A/S
HanAll Biopharma
Hankang Capital
Harmonic Pain Solutions
HBM Partners AG
Health Innovation Capital
Healthcare Angels
HEDA Ventures
Hercules Capital
Hestia Investments Ltd.
Hevolution
Hillhouse Capital
IAMA Therapeutics S.r.l.
Illumina Ventures
Impact India Investment Partners LLC (3i Partners)
In-Q-Tel
INBRAIN Neuroelectronics
Indaco Venture Partners SGR S.p.A.
Industrifonden
Innovation Works
IPF Partners
Ipsen
Jeito Capital
Jiangsu Nhwa Pharmaceutical Co., Ltd
JLS Fund
Johnson & Johnson Innovation – JJDC, Inc.
Joyance Partners
JT Pharma
Junson Capital
Kaleida Capital

​Last updated on: 3rd of January

Keystone Bio, Inc.
Kynexis Therapeutics
Lactocore Inc.
Ladenburg Thalmann & Co. Inc.
Landmark Family Office/Landmark Angels
LDV Partners
Lifespan Vision Ventures
Lightstone Ventures
Lilly Asia Ventures
LMU Munich
Longevity Biotech
Lumanity
Lumira Ventures
Lundbeckfonden BioCapital
Lynx Financial Hong Kong Ltd.
Lys Therapeutics
M Ventures
Medicxi
MedinCell S.A.
MedTech Strategist
Medtronic
Medtronic GC Ventures
Mid Atlantic Bio Angels
Minoryx Therapeutics S.L.
Mission BioCapital
Momentum Biotech LLC
Monument Therapeutics Limited
MP Healthcare Venture Management, Inc.
MRL Venture Funds at Merck
National Institute on Aging
National Institutes of Health
Neo Auvra Corp.
NeuCyte, Inc.
Neuro-Innovators, LLC
Neuromod Devices
NeuroPn Therapeutics, Inc.
Neurotech Reports
NeuroTrauma Sciences, LLC
Neurvati Neurosciences, Inc.
NeuVasQ Biotechnologies
New Harbor Venture Partners, LLC
New Science Fund
New World Strategic Investment Company Limited
Newronika S.p.A.
Nexus NeuroTech Ventures
NI Research Inc.
Nine Square Therapeutics, Inc.
Noema Pharma AG
NovaQuest Capital Management LLC
Novo Holdings
NRW Venture
NRx Pharmaceuticals, Inc.
Nucleon Research LLC
NurrOn Pharmaceuticals Inc.
Ontario Brain Institute
Ontario Teachers’ Pension Plan
Oppenheimer & Co. Inc.
Oryzon Genomics, S.A.
Otsuka Holdings Co., Ltd.
Otsuka Pharmaceuticals Europe Ltd.
Palo Alto Investors
Palo Santo
Panakès Partners SGR SpA
Pangea Bio
Parow Entheobiosciences LLC
PATH Biotech LLC
PharmaVentures Ltd
Pivotal Life Sciences
PJT Partners
Playground Global
Prevail Partners LLC
Pritzker Neuropsychiatric Disorders Research Consortium
Profound Ventures
ProNeurogen, Inc.
Protobios
Psilera Inc.
PsychoGenics, Inc.
PsyMed Ventures
Pureos Bioventures
Qiming Venture Partners
Quan Capital
Quince Therapeutics
Raya Therapeutic, Inc.
Raymond James Financial, Inc.
Real Endpoints
Relentless Venture Fund
Remiges Ventures, Inc.
Reunion Neuroscience, Inc.
Roche
RYSE Asset Management
Samsara BioCapital
Satori Neuro
Sensorium Therapeutics
Seventure Partners
Shanda Group
Silicon Valley Venture Growth Partners
Sinaptica Therapeutics, Inc.
Sixty Degree Capital
Sofinnova Investments, Inc.
Solasta Ventures
Sony Ventures
STALICLA SA
SternAegis Ventures
Stifel
SV Health Investors
Switch Therapeutics
Synendos Therapeutics AG
Tailwinds VC
Tessara Therapeutics Pty Ltd.
The Benchmark Company, LLC
The Fulford Group Ltd.
The Michael J. Fox Foundation for Parkinson's Research
Theracast
Theranexus SA
TikoMed AB
Tonix Pharmaceuticals Holding Corp.
TransPacifc Venture Capital Partners
Treo Ventures
TruVenturo GmbH
Two Sigma Ventures
UCB Ventures
UCL Technology Fund
V-Bio Ventures
Vine Ventures
Vivo Capital
WBB Securities, LLC
Wellington Partners
Wilson Hill Ventures
WPSS.bio
WRF Capital
Wyss Center for Bio and Neuroengineering
Xontogeny
Zeto, Inc.